Pavilion Capital and Hansjörg Wyss featured in a series B round for Harvard-founded ReadCoor, whose existing shareholders also include Lilly Asia Ventures.
ReadCoor, a US-based gene sequencing spinout of Harvard University, obtained $27m on Friday in a series B round featuring Singaporean government-owned investment vehicle Pavilion Capital.
Investment firm Decheng Capital also participated, as did private investor Hansjörg Wyss, founder of Harvard’s Wyss Institute for Biologically Inspired Engineering, and unnamed existing investors.
Founded in 2016, ReadCoor supplies molecular sequencing products that apply fluorescence to mark out molecular targets before plotting them as coordinates on a 3D image of the sample.
